Rosiglitazone Side Effects

Ennis & Ennis is a national mass tort law firm with offices in Washington DC and Florida (Miami & Ft. Lauderdale) and provides the Avandia Lawyer site for people to contact to give details of loved ones who have been treated with rosiglitazone/Avandia and consequently suffered the rosiglitazone side effects of heart attacks, strokes or congestive heart failure. A suggested rosiglitazone recall was made by David Graham, a top safety scientist and eventually, in 2007, the US government began to look into the safety concerns about the diabetic treatment. The Avandia Lawyer site of Ennis & Ennis informs that patients who have been treated with the drug and experienced rosiglitazone side effects may be entitled to compensation.

The Avandia Lawyer informs that when Graham urged that the drug be removed from the market, he cited research to make his argument that there is no evidence of major health benefits from taking the drug, and that leaving it on the market may "cost thousands of lives." The rosiglitazone recall was supported by the study in the New England Journal of Medicine which linked Avandia/rosiglitazone with a 43 percent higher risk of heart attacks.

The Avandia Lawyer of Ennis & Ennis has a team of professionals dedicated to helping clients deal with all aspects of an Avandia/rosiglitazone side effects claims, and will help to get them a fair settlement or verdict in an efficient and expeditious manner. There is clinical proof that rosiglitazone side effects are being experienced, especially by those who are known to have underlying heart disease or who are at high risk of heart attacks. The FDA warns patients to speak to their physicians about their continued use of Avandia. The FDA's Safety Alert follows a study released on the same day, which appeared in the June 14, 2007 issue of the New England Journal of Medicine. This type of study, known as a meta-analysis, evaluated forty-two (42) separate studies comparing patients using Avandia (rosiglitazone) to patients who were not using Avandia.

This study concludes that patients taking Avandia (rosiglitazone) face a 43 percent increased risk of rosiglitazone side effects of heart attack, and a 64 percent increased risk of dying from strokes, aneurysms, congestive heart failure and arrhythmia. The Avandia Lawyer is empathetic but forceful, and will uncover justice for each unique case of rosiglitazone through every step of the legal process. Avandia Lawyer informs that GlaxoSmithKlein, the maker of Avandia/rosiglitazone, disputed Graham's findings and the company said many studies have already been conducted, involving thousands of subjects, and that "there is no consistent or systematic evidence that Avandia increases the risk of heart attacks or death from cardiovascular disease compared to other drugs." The Avandia Lawyer indicates that on November 14, 2007 the FDA ordered an Avandia Black Box Warning.

The rosiglitazone side effects keep cropping up and on July 25, 2009, researchers from the activist group Public Citizen said that rosiglitazone side effects now included liver failure. They wrote in the journal Pharmacoepidemiology and Drug Safety that a review of adverse events reported to the Food and Drug Administration found eleven deaths due to liver toxicity between 1997 and 2006 associated with the drug.